[
  {
    "date": "2023-12-30",
    "symbol": "BFNH",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2023,
    "currentfiscalyearenddate": "--12-31",
    "entityfilenumber": "000-51074",
    "entityregistrantname": "BIOFORCE NANOSCIENCES HOLDINGS, INC.",
    "entitycentralindexkey": 1310488,
    "entitytaxidentificationnumber": "74-3078125",
    "entityincorporationstatecountrycode": "NV",
    "entityaddressaddressline1": "2020 General Booth Blvd",
    "entityaddressaddressline2": "Suite 230",
    "entityaddresscityortown": "Virginia Beach",
    "entityaddressstateorprovince": "VA",
    "entityaddresspostalzipcode": 23454,
    "cityareacode": 757,
    "localphonenumber": "306-6090",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorname": "BF Borgers CPA PC",
    "auditorfirmid": 5041,
    "auditorlocation": "Lakewood, CO",
    "cashandcashequivalentsatcarryingvalue": 638,
    "assetscurrent": 638,
    "assets": 638,
    "accountspayableandaccruedliabilitiescurrent": 2649,
    "accruedsalariescurrentandnoncurrent": 1596517,
    "duetorelatedparties": 220702,
    "liabilitiescurrent": 1819868,
    "liabilities": 1819868,
    "commonstockvalue": 29272,
    "additionalpaidincapitalcommonstock": 158781227,
    "retainedearningsaccumulateddeficit": -160629729,
    "stockholdersequity": -1819230,
    "liabilitiesandstockholdersequity": 638,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 900000000,
    "commonstocksharesissued": 29271755,
    "commonstocksharesoutstanding": 29271755,
    "compensationexpenseexcludingcostofgoodandservicesold": 423000,
    "generalandadministrativeexpense": 48953,
    "operatingexpenses": 471953,
    "netincomeloss": -471953,
    "weightedaveragenumberofsharesoutstandingbasic": 29271755,
    "weightedaveragenumberofdilutedsharesoutstanding": 29271755,
    "earningspersharebasic": -0.02,
    "earningspersharediluted": -0.02,
    "increasedecreaseinaccountspayableandaccruedliabilities": 2251,
    "increasedecreaseinaccruedsalaries": 423000,
    "netcashprovidedbyusedinoperatingactivities": -46702,
    "proceedsfromrelatedpartydebt": 46606,
    "netcashprovidedbyusedinfinancingactivities": 46606,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -96,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 638,
    "sharesoutstanding": 29271755,
    "expenses": 46606,
    "adjustmentstoadditionalpaidincapitalother": 220702,
    "preferredstocksharesauthorized": 100000000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstockconversionbasis": "Preferred stock can be convertedinto 100 shares of common stock, have dividend rights at 100 times common and have voting rights equal to 100 shares of common stock."
  },
  {
    "date": "2022-12-30",
    "symbol": "BFNH",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "currentfiscalyearenddate": "December 31",
    "entityfilenumber": "000-51074",
    "entityregistrantname": "BIOFORCE NANOSCIENCES HOLDINGS, INC.",
    "entitycentralindexkey": 1310488,
    "entitytaxidentificationnumber": "74-3078125",
    "entityincorporationstatecountrycode": "Nevada",
    "entityaddressaddressline1": "2020 General Booth Blvd",
    "entityaddressaddressline2": "Suite 230",
    "entityaddresscityortown": "Virginia Beach",
    "entityaddressstateorprovince": "VA",
    "entityaddresspostalzipcode": 23454,
    "cityareacode": 757,
    "localphonenumber": "306-6090",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "No",
    "auditorname": "BF Borgers CPA PC",
    "auditorfirmid": 5041,
    "auditorlocation": "Lakewood,CO",
    "cashandcashequivalentsatcarryingvalue": 734,
    "assetscurrent": 734,
    "assets": 734,
    "accountspayableandaccruedliabilitiescurrent": 398,
    "accruedsalariescurrentandnoncurrent": "null",
    "duetorelatedparties": 174096,
    "liabilitiescurrent": "null",
    "liabilities": "null",
    "commonstockvalue": 29272,
    "additionalpaidincapitalcommonstock": "null",
    "retainedearningsaccumulateddeficit": "-null",
    "stockholdersequity": "-null",
    "liabilitiesandstockholdersequity": 734,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "compensationexpenseexcludingcostofgoodandservicesold": 423000,
    "generalandadministrativeexpense": 62514,
    "operatingexpenses": 485514,
    "netincomeloss": -485514,
    "weightedaveragenumberofcommonsharesbasicanddiluted": "null",
    "netlosspercommonsharesbasicanddiluted": -0.02,
    "increasedecreaseinprepaidexpense": -40,
    "increasedecreaseinaccountspayableandaccruedliabilities": -5915,
    "increasedecreaseinaccruedsalaries": 423000,
    "netcashprovidedbyusedinoperatingactivities": -68389,
    "capitalcontributions": 100,
    "proceedsfromrelatedpartydebt": 57918,
    "netcashprovidedbyusedinfinancingactivities": 58018,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -10371,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 734,
    "sharesoutstanding": "null",
    "stockissuedduringperiodvalueconversionofunits": 100,
    "expenses": 57917,
    "adjustmentstoadditionalpaidincapitalother": 174096,
    "preferredstocksharesauthorized": "null",
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstockconversionbasis": "Preferred stock can be converted into 100 shares of common stock, have dividend rights at 100 timescommon and have voting rights equal to 100 shares of common stock."
  },
  {
    "date": "2021-12-30",
    "symbol": "BFNH",
    "period": "FY",
    "entitycentralindexkey": 1310488,
    "documentperiodenddate": "2021-12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityregistrantname": "BIOFORCE NANOSCIENCES HOLDINGS, INC.",
    "entityincorporationstatecountrycode": "NV",
    "entityfilenumber": "000-51074",
    "entitytaxidentificationnumber": "74-3078125",
    "entityaddressaddressline1": "2020 General Booth Blvd.",
    "entityaddressaddressline2": "Suite 230",
    "entityaddresscityortown": "Virginia Beach",
    "entityaddressstateorprovince": "VA",
    "entityaddresspostalzipcode": 23454,
    "cityareacode": 757,
    "localphonenumber": "306-6090",
    "security12btitle": "N/A",
    "tradingsymbol": "N/A",
    "securityexchangename": "NONE",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "icfrauditorattestationflag": "true",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "auditorname": "BF Borgers CPA PC",
    "auditorlocation": "Lakewood, CO",
    "auditorfirmid": 5041,
    "cashandcashequivalentsatcarryingvalue": 11105,
    "prepaidexpensecurrent": 40,
    "assetscurrent": 11145,
    "assets": 11145,
    "accountspayableandaccruedliabilitiescurrent": 6313,
    "accruedsalariescurrentandnoncurrent": 750517,
    "duetorelatedpartiescurrent": 116178,
    "liabilitiescurrent": 873008,
    "liabilities": 873008,
    "commonstockvalue": 29272,
    "additionalpaidincapitalcommonstock": 158781127,
    "retainedearningsaccumulateddeficit": -159672262,
    "stockholdersequity": -861863,
    "liabilitiesandstockholdersequity": 11145,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 900000000,
    "commonstocksharesissued": 29271755,
    "commonstocksharesoutstanding": 29271755,
    "compensationexpenseexcludingcostofgoodandservicesold": 423000,
    "generalandadministrativeexpense": 78955,
    "operatingexpenses": 501955,
    "netincomeloss": -501955,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 29271755,
    "earningspersharebasicanddiluted": -0.02,
    "increasedecreaseinprepaidexpense": 40,
    "increasedecreaseinaccountspayableandaccruedliabilities": 1223,
    "increasedecreaseinaccruedsalaries": 423000,
    "netcashprovidedbyusedinoperatingactivities": -77772,
    "proceedsfromrelatedpartydebt": 49012,
    "netcashprovidedbyusedinfinancingactivities": 49012,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -28760,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 49012,
    "adjustmentstoadditionalpaidincapitalother": 116178,
    "sharesissuedpricepershare": 0.79
  },
  {
    "date": "2020-12-30",
    "symbol": "BFNH",
    "period": "FY",
    "entityregistrantname": "BIOFORCE NANOSCIENCES HOLDINGS, INC.",
    "entitycentralindexkey": 1310488,
    "documenttype": "10-K",
    "documentperiodenddate": "2020-12-31",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2020,
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "NV",
    "entityfilenumber": "000-51074",
    "cashandcashequivalentsatcarryingvalue": 39865,
    "assetscurrent": 39865,
    "assets": 39865,
    "accountspayableandaccruedliabilitiescurrent": 5090,
    "accruedsalariescurrentandnoncurrent": 327517,
    "duetorelatedpartiescurrent": 67166,
    "liabilitiescurrent": 399773,
    "liabilities": 399773,
    "commonstockvalue": 29272,
    "additionalpaidincapitalcommonstock": 158781127,
    "retainedearningsaccumulateddeficit": -159170307,
    "stockholdersequity": -159170307,
    "liabilitiesandstockholdersequity": 39865,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 900000000,
    "commonstocksharesissued": 29271755,
    "commonstocksharesoutstanding": 29271755,
    "compensationexpenseexcludingcostofgoodandservicesold": 158327517,
    "generalandadministrativeexpense": 81038,
    "operatingexpenses": 158408555,
    "netincomeloss": -158408555,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 16304367,
    "earningspersharebasicanddiluted": -9.72,
    "commonstockissuedtopayaccountspayable": 1338,
    "commonandpreferredstockissuedforcurrentyearboardofdirectorscompensation": 158000000,
    "increasedecreaseinprepaidexpense": -6000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -5158,
    "increasedecreaseinaccruedsalaries": 327517,
    "netcashprovidedbyusedinoperatingactivities": -80196,
    "proceedsfromrelatedpartydebt": 67166,
    "netcashprovidedbyusedinfinancingactivities": 67166,
    "cashandcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -13030,
    "commonstockissuedtopaystockpayable": 1339,
    "commonstockissuedtopayaccountspayableshares": 1167,
    "stockissuedduringperiodvalueissuedforservices": 2000,
    "stockissuedduringperiodsharesissuedforservices": 2000000,
    "incrementalcommonsharesvalueattributabletoconversionofpreferredstock": -2000,
    "incrementalcommonsharesattributabletoconversionofpreferredstock": -2000000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 67166,
    "adjustmentstoadditionalpaidincapitalother": 67166,
    "conversionofstocksharesissued1": 1167,
    "proceedsfromotherequity": 1339,
    "sharesissuedpricepershare": 0.79
  },
  {
    "date": "2019-12-30",
    "symbol": "BFNH",
    "period": "FY",
    "entityregistrantname": "BIOFORCE NANOSCIENCES HOLDINGS, INC.",
    "entitycentralindexkey": 1310488,
    "documenttype": "10-K",
    "documentperiodenddate": "2019-12-31",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2019,
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "NV",
    "entityfilenumber": "000-51074",
    "cashandcashequivalentsatcarryingvalue": 52895,
    "prepaidexpensecurrent": 6000,
    "assetscurrent": 58895,
    "assets": 58895,
    "accountspayableandaccruedliabilitiescurrent": 10248,
    "stockpayablecurrent": 1339,
    "liabilitiescurrent": 11587,
    "liabilities": 11587,
    "commonstockvalue": 15271,
    "additionalpaidincapitalcommonstock": 793789,
    "retainedearningsaccumulateddeficit": -761752,
    "stockholdersequity": -761752,
    "liabilitiesandstockholdersequity": 58895,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 900000000,
    "commonstocksharesissued": 15270588,
    "commonstocksharesoutstanding": 15270588,
    "revenues": 13415,
    "costofrevenue": 13415,
    "grossprofit": 4360,
    "generalandadministrativeexpense": 50898,
    "operatingincomeloss": -46538,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -46538,
    "netincomeloss": -46538,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 15264706,
    "commonstockissuedtopayaccountspayable": 16147,
    "increasedecreaseinaccountsreceivable": -5735,
    "increasedecreaseinprepaidexpense": 6000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 4925,
    "increasedecreasestockpayble": -1339,
    "netcashprovidedbyusedinoperatingactivities": -24383,
    "proceedsfromcontributedcapital": 47886,
    "cashandcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 23503,
    "capitalcontributiondirectors": 47886,
    "commonstockissuedtopayaccountspayableshares": 8870,
    "duefrombanks": 52290,
    "cash": 605,
    "filingfeescurrent": 6000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 47886,
    "adjustmentstoadditionalpaidincapitalother": 47886,
    "conversionofstocksharesissued1": 8870,
    "proceedsfromotherequity": 16156,
    "currentincometaxexpensebenefit": 12555,
    "operatinglosscarryforwardsvaluationallowance": 114200,
    "deferredtaxassetsnet": 30855
  }
]